AKI Risk in COVID-19 vs Flu Not Disproportionately Higher With RAASi Use

RAAS inhibitor use is not associated with a disproportionately higher risk for acute kidney injury in patients with COVID-19.

Related Keywords

Vanderbilt University ,Tennessee ,United States ,Chapel Hill ,Eric Judd ,Amyk Mottl ,Michaele Matheny ,Edwardd Siew ,Vanderbilt University Medical Center ,University Of North Carolina ,Division Of Nephrology ,Biomedical Informatics ,Vanderbilt University Medical ,Birmingham Marnix ,Medicine Division ,North Carolina ,Kidney Int ,